J. Goldman & CO LP Bridge Bio Pharma, Inc. Call Options Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $290,385 - $751,275	40,500 New	40,500 $671,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $198,180 - $463,320	-27,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $307,260 - $1.44 Million	27,000 New	27,000 $450,000

294

171M

10.4M

2.36M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.07B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.